Related Experiment Videos
Anterior ischemic optic neuropathy in type I diabetes
12nd Clinica Oculistica, University of Florence, Italy.
Metabolic, Pediatric, and Systemic Ophthalmology (New York, N.Y. : 1985)
|January 1, 1986
Summary
Anterior ischemic optic neuropathy (A.I.O.N.) can affect diabetic patients, potentially becoming bilateral. This case study highlights a benign presentation in an insulin-dependent diabetic woman, supporting A.I.O.N. diagnosis.
Area of Science:
- Ophthalmology
- Endocrinology
- Neurology
Background:
- Anterior ischemic optic neuropathy (A.I.O.N.) is a potential complication in diabetic patients, characterized by optic disc edema.
- Diabetic patients, regardless of age, are susceptible to A.I.O.N., with a higher likelihood of bilateral presentation compared to non-diabetics.
Observation:
- A 41-year-old insulin-dependent diabetic woman experienced A.I.O.N. in her right eye, followed by the same condition in her left eye five years later.
- The clinical course for both eyes was relatively benign, resulting in good functional recovery.
Findings:
- The patient was treated with high doses of Sodium Salicylate and Sulfinpyrazone.
- Visual evoked potential (VEP) testing supported the diagnosis of A.I.O.N.
- The case represents an intermediate position within the spectrum of A.I.O.N. severity in type-1 diabetes, linked to microangiopathy, rheological anomalies, and atherosclerotic lesions affecting posterior ciliary arteries.
Implications:
- This case underscores the importance of recognizing A.I.O.N. in diabetic individuals and its variable clinical presentations.
- Effective management strategies, including pharmacological interventions, can lead to favorable outcomes.
- Further research into the pathogenesis and optimal treatment of A.I.O.N. in diabetes is warranted.